
ACORQ
Healthcare · Drug Manufacturers - Specialty & Generic
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 14, 2024 | Before the open | — | -225.81 | — |
| Nov 14, 2023 | Time not confirmed | — | -7.16 | — |
| Aug 9, 2023 | Time not confirmed | — | -7.55 | — |
| May 12, 2023 | Time not confirmed | — | -13.83 | — |
| Mar 9, 2023 | Time not confirmed | — | 8.76 | — |
| Nov 2, 2022 | Time not confirmed | — | -11.41 | — |
| Aug 5, 2022 | Time not confirmed | — | -55.63 | — |
| May 12, 2022 | Time not confirmed | — | -37.01 | — |
| Mar 10, 2022 | Time not confirmed | — | -34.69 | — |
| Nov 10, 2021 | Time not confirmed | — | -48.64 | — |
| Aug 6, 2021 | Time not confirmed | — | -45.76 | — |
| May 7, 2021 | Time not confirmed | — | -70.65 | — |
| Mar 5, 2021 | Time not confirmed | — | -196.47 | — |
| Nov 4, 2020 |
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also…
| Time not confirmed |
| — |
| 6.37 |
| — |
| Aug 5, 2020 | Time not confirmed | — | -43.82 | — |
| May 6, 2020 | Time not confirmed | — | -16.28 | — |
| Feb 13, 2020 | Time not confirmed | — | 165.44 | — |
| Nov 5, 2019 | Time not confirmed | — | -665.62 | — |
| Aug 2, 2019 | Time not confirmed | — | -69.46 | — |
| May 2, 2019 | Time not confirmed | — | -120.34 | — |
| Feb 15, 2019 | Time not confirmed | — | 24.19 | — |
| Oct 31, 2018 | Time not confirmed | — | -35.38 | — |
| Aug 2, 2018 | Time not confirmed | — | 117.45 | — |
| May 2, 2018 | Time not confirmed | — | -21.15 | — |
| Feb 15, 2018 | Time not confirmed | — | -443.95 | — |